Literature DB >> 24389076

Programmed death-1 (PD-1) polymorphisms in Chinese patients with esophageal cancer.

Hao Qiu1, Liang Zheng2, Weifeng Tang3, Pengfei Yin1, Feng Cheng1, Lixin Wang4.   

Abstract

OBJECTIVES: Esophageal cancer is an extremely aggressive gastrointestinal malignancy, which appears to result from a complex interplay between genetic and environmental agents. The genetic loci conferring susceptibility have yet to be fully defined. Considering the role of programmed death-1 (PD-1) in immune regulation and tumor pathogenesis, we genotyped three functional single nucleotide polymorphisms (SNPs) in PD-1 in a Chinese population to explore whether these three SNPs confer susceptibility to esophageal cancer. DESIGN AND METHODS: A total of 629 new diagnosed esophageal squamous cell carcinoma (ESCC) cases and 686 controls were recruited for this hospital-based case-control study. Genotyping was performed by the polymerase chain reaction-ligase detection reaction (PCR-LDR) method in all the subjects.
RESULTS: In the recessive model, when the PD-1 rs10204525 AA/AG genotypes were used as the reference group, the GG homozygote genotype was associated with a borderline statistically decreased risk of ESCC [adjusted odds ratio (OR)=0.68, 95% confidence interval (CI)=0.45-1.03, P=0.067]. However, there were no significant associations between the other two SNPs and ESCC risk. Stratified analyses showed that a significantly decreased risk of ESCC associated with PD-1 rs10204525 A>G polymorphism was overt among male and younger patients.
CONCLUSIONS: Our results demonstrate for the first time that the PD-1 rs10204525 polymorphism might contribute to susceptibility of ESCC and may therefore support the hypothesis that genetic variants, influencing T cell activity-associated gene regulation, may modify cancer risk.
Copyright © 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Esophageal cancer; Molecular epidemiology; PD-1; Polymorphisms; Susceptibility

Mesh:

Year:  2014        PMID: 24389076     DOI: 10.1016/j.clinbiochem.2013.12.023

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  15 in total

1.  Variations in genes involved in immune response checkpoints and association with outcomes in patients with resected colorectal liver metastases.

Authors:  S Stremitzer; Y Sunakawa; W Zhang; D Yang; Y Ning; S Stintzing; A Sebio; S Yamauchi; S Matsusaka; R El-Khoueiry; J Stift; F Wrba; T Gruenberger; H-J Lenz
Journal:  Pharmacogenomics J       Date:  2015-03-10       Impact factor: 3.550

2.  Programmed death-1 (PD-1) polymorphism is associated with gastric cardia adenocarcinoma.

Authors:  Weifeng Tang; Yu Chen; Shuchen Chen; Bin Sun; Haiyong Gu; Mingqiang Kang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

3.  The concentration of programmed cell death-ligand 1 in the peripheral blood is a useful biomarker for esophageal squamous cell carcinoma.

Authors:  Yasunori Akutsu; Kentaro Murakami; Masayuki Kano; Takeshi Toyozumi; Yasunori Matsumoto; Masahiko Takahashi; Ryota Otsuka; Nobufumi Sekino; Masaya Yokoyama; Tadashi Shiraishi; Hisahiro Matsubara
Journal:  Esophagus       Date:  2018-02-07       Impact factor: 4.230

4.  Lack of association between cyclin D1 A870G (rs9344) polymorphism and esophageal squamous cell carcinoma risk: case-control study and meta-analysis.

Authors:  Weifeng Tang; Ping Yu; Yafeng Wang; Mingqiang Kang; Bin Sun; Jun Yin; Haiyong Gu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 5.  PD-1 and cancer: molecular mechanisms and polymorphisms.

Authors:  Arash Salmaninejad; Vahid Khoramshahi; Alireza Azani; Ehsan Soltaninejad; Saeed Aslani; Mohammad Reza Zamani; Masoud Zal; Abolfazl Nesaei; Sayed Mostafa Hosseini
Journal:  Immunogenetics       Date:  2017-06-22       Impact factor: 3.330

Review 6.  Programmed Cell Death-1 Polymorphisms Decrease the Cancer Risk: A Meta-Analysis Involving Twelve Case-Control Studies.

Authors:  Wenjing Dong; Mancheng Gong; Zhirong Shi; Jianjun Xiao; Junkai Zhang; Jiewen Peng
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

Review 7.  The association between polymorphisms in the PDCD1 gene and the risk of cancer: A PRISMA-compliant meta-analysis.

Authors:  Jie Zhang; Taiqiang Zhao; Chengjie Xu; Jiang Huang; Hua Yu
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

8.  Programmed death-1 polymorphisms is associated with risk of esophagogastric junction adenocarcinoma in the Chinese Han population: A case-control study involving 2,740 subjects.

Authors:  Weifeng Tang; Shuchen Chen; Yu Chen; Jihong Lin; Jiangbo Lin; Yafeng Wang; Chao Liu; Mingqiang Kang
Journal:  Oncotarget       Date:  2017-06-13

9.  PD-1 rs2227982 Polymorphism Is Associated With the Decreased Risk of Breast Cancer in Northwest Chinese Women: A Hospital-Based Observational Study.

Authors:  Hong-Tao Ren; Yi-Ming Li; Xi-Jing Wang; Hua-Feng Kang; Tian-Bo Jin; Xiao-Bin Ma; Xing-Han Liu; Meng Wang; Kang Liu; Peng Xu; Qing-Ling Yao; Zhi-Jun Dai
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

10.  IL-17A promotes migration and tumor killing capability of B cells in esophageal squamous cell carcinoma.

Authors:  Lin Lu; Chengyin Weng; Haibo Mao; Xisheng Fang; Xia Liu; Yong Wu; Xiaofei Cao; Baoxiu Li; Xiaojun Chen; Qinquan Gan; Jianchuan Xia; Guolong Liu
Journal:  Oncotarget       Date:  2016-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.